• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Nutraceuticals for Men: Muscle Health and Performance Nutrition

    Aging in Place: Healthy Lifestyles Supplement Science-Based Solutions

    Getting an Edge in Esports: Meeting the Health Needs of Competitive Gamers

    Beyond CBD: Cannabis Compounds Warrant Recognition and More Research

    Leveling Out the Energy Segment for Mainstream, and Rethinking Caffeine
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Thorne Relaunches Gut Health Test with Microbiome Wipe

    Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports

    GC Rieber Foundations Expand Philanthropic Efforts

    Danone Celebrates 10th anniversary of Grant Program for Probiotics Research

    Stratum Nutrition’s Patent Portfolio Grows to Europe and Canada
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    GC Rieber Foundations Expand Philanthropic Efforts

    Danone Celebrates 10th anniversary of Grant Program for Probiotics Research

    Botanical Ingredient MorActive Evidenced to Relieve Back Discomfort

    Cargill’s Stevia Sustainability Program Benchmarked by FSA

    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Thorne Relaunches Gut Health Test with Microbiome Wipe

    Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports

    GC Rieber Foundations Expand Philanthropic Efforts

    Danone Celebrates 10th anniversary of Grant Program for Probiotics Research

    Stratum Nutrition’s Patent Portfolio Grows to Europe and Canada
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Thorne Relaunches Gut Health Test with Microbiome Wipe

    Danone Celebrates 10th anniversary of Grant Program for Probiotics Research

    Beyond Raw Launches Concept X Pre-Workout Line

    Botanical Ingredient MorActive Evidenced to Relieve Back Discomfort

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Verdure Sciences

    Gencor

    Aiya America, Inc. (Aiya Matcha)

    Applied Food Sciences, Inc.

    Sabinsa Corporation
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Verdure Sciences

    Gencor

    Aiya America, Inc. (Aiya Matcha)

    Applied Food Sciences, Inc.

    Sabinsa Corporation
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Illegal Ephedrine-Like Drug Found in U.S. Diet/Sports Nutrition Products

    FDA sends warning letters to seven firms marketing products containing unapproved oxilofrine.

    Illegal Ephedrine-Like Drug Found in U.S. Diet/Sports Nutrition Products
    Oxilofrine has not been approved in the U.S. for use in OTC drugs or dietary supplements.
    Related CONTENT
    • FDA Issues Draft Guidance on NDI Enforcement Discretion
    • Consumer Conviction: Results of consumer satisfaction study on mental wellness and sleep.
    • Draft Senate Bill to Reauthorize FDA User Fees Includes Dietary Supplement Listing Provision
    • FDA Warns About Steroids or Steroid-Like Substances in Bodybuilding Products
    • Experts Debate Role of Supplements in Improving Public Health in EU
    Sean Moloughney, Editor04.08.16
    Days after FDA issued seven warning letters dated Mar. 31 to companies selling products that contain methylsynephrine (also known as oxilofrine), a study published online in Drug Testing and Analysis on Apr. 7 indicated that 14 over-the-counter dietary supplement products (out of 27 brands tested) contained this unapproved pharmaceutical stimulant, presenting a potentially serious risk to consumers.
     
    Oxilofrine, 4-[1-hydroxy-2-(methylamino)propyl]phenol (also known as methylsynephrine, p-hydroxyephedrine, oxyephedrine, 4-HMP and suprifen), is a pharmaceutical drug developed in Europe in the 1930s to stimulate the heart, increase blood pressure and improve oxygen exchange, according to researchers. However, it has never been approved in the U.S. for use as a medication or as a dietary supplement. 
     
    Several professional athletes also have been disqualified from sports due to testing positive for oxilofrine, which is banned by the World Anti-Doping Agency (WADA) and most major sports organizations including Major League Baseball (MLB) and the National Football League (NFL).          
     
    Consumption of supplements containing oxilofrine may also pose serious health risks. For example, one brand of supplements containing oxilofrine has been linked to serious adverse events including vomiting, agitation, and cardiac arrest.
     
    According to the FDA, oxilofrine is an illegal dietary ingredient, which means products containing oxilofrine are considered misbranded under the law. Warning Letters were delivered to the following companies (for their respective products): Chaotic Labz (Malice), Line One Nutrition, Inc (Fat Burning Lean Pills), m4 Nutrition Companies LLC (iBurn 2, which contains methylsynephrine and picamilon—another ingredient FDA has said is an unapproved New Dietary Ingredient), NutraClipse, Inc. (Thermobombs), Swagger Supps (Miami Lean), and Xcel Sports Nutrition, LLC (Leaner You). The companies have 15 days from receipt of the warning letters to respond to FDA with specific, corrective actions.
     
    Steve Mister, president and CEO of the Council for Responsible Nutrition (CRN), Washington, D.C., applauded FDA for taking action against companies breaking the law and potentially putting consumers at risk.
     
    “Selling products that list methylsynephrine as a dietary ingredient is illegal because the ingredient, also known as oxilofrine, has not been subjected to the New Dietary Ingredient (NDI) notification process, a requirement under the law,” he said. “Responsible marketers and manufacturers of supplements who compose the mainstream dietary supplement industry are in lockstep with FDA when it comes to enforcing the law and protecting the safety of their consumers, and we strongly urge the companies that received these warning letters—and any others that may be selling this illegal ingredient—to heed the agency’s warning immediately.
     
    Study Details
    For the study published in Drug Testing and Analysis, researchers from Harvard Medical School (including lead author Dr. Pieter Cohen), NSF International, the National Center for Natural Products Research (NCNPR) at the University of Mississippi and the National Institute for Public Health and the Environment in the Netherlands (RIVM) designed their study to determine the presence and quantity of oxilofrine in dietary supplements sold in the U.S. A validated ultra-high performance liquid chromatography-quadrupole time of flight-mass spectrometry method was developed for the identification and quantification of oxilofrine.
     
    The separation was achieved using a reversed phase column, mass spectrometry detection, and a water/acetonitrile gradient as the mobile phase. The presence of oxilofrine was confirmed using a reference standard. They analyzed 27 brands of supplements labeled as containing a synonym of oxilofrine (methylsynephrine) and found that oxilofrine was present in 14 different brands (52%) at dosages ranging from 0.0003 to 75 mg per individual serving. Of the supplements containing oxilofrine, 43% (6 of 14) contained pharmaceutical or greater dosages of oxilofrine. Following instructions on the label, consumers could ingest as much as 250 mg of oxilofrine per day. This dosage is twice the typical adult dosage prescribed by physicians in other countries where the drug is approved for use during anesthesia and for treating a variety of medical conditions. 
     
    Oxilofrine could be disguised or unlisted on the label and poses serious health risks to consumers, according to the researchers. Oxilofrine has been studied in animals and humans and found to cause effects on the heart similar to ephedrine, a compound banned by FDA in 2004 due to serious side effects. Since then, scientists at NSF International have discovered several unapproved and potentially dangerous replacement stimulants such as DEPEA, DMAA, DMBA and now oxilofrine in dietary supplements.
     
    According to the analysis, 26 adverse events have been reported in the Netherlands linked to supplements containing oxilofrine. These supplements led to nausea and vomiting, tachycardia, chest pain and cardiac arrest. Additionally, oxilofrine is often disguised on labels as “methylsynephrine” or “extract of Acacia rigidula.”
     
    Researcher Reactions
    “Adolescents who use these products might be placing themselves at risk of serious harm. The larger-than-adult doses we found might overstimulate their smaller, growing bodies,” said Dr. Cohen, an assistant professor of medicine at Harvard Medical School who has conducted extensive research on supplements. “In countries where oxilofrine is prescribed by doctors, the usual amount of the drug for adolescents is 24 mg or less. We found amounts in supplements of oxilofrine more than three times higher than the usual pediatric dose. Combined with physical activity and other stimulants commonly found in supplements, the consequences could be catastrophic.”
     
    This is the fourth time in three years that the research team has found unapproved stimulants disguised in supplements as botanical ingredients. “This compound was found in 14 supplements which are used as either dieting aides or pre-workout supplements,” said John Travis, NSF International research scientist. “As a public health organization we want to warn consumers about these compounds that may harm instead of improve their health.”
     
    “The presence of potentially harmful compounds such as oxilofrine, disguised as ‘methylsynephrine’ or ‘extract of Acacia rigidula,’ in over-the-counter supplements is illegal, and consumers should be aware of and avoid products containing these compounds. NSF International developed a testing and certification program that verifies supplement labels are accurate and the product itself is free from harmful levels of contaminants such as oxilofrine. We urge consumers to seek NSF certified dietary supplements to avoid unintentionally consuming harmful compounds,” Mr. Travis added.
     
    NSF International helped develop the only accredited American National Standard for dietary supplements (NSF/ANSI 173). NSF’s accredited dietary supplement certification program is based on this standard. The program includes a label and formulation review, testing to verify the supplement does not contain harmful levels of contaminants and two facility audits annually to confirm compliance to Good Manufacturing Practices (GMPs). Products certified to the stringent NSF Certified for Sport program include additional steps to screen supplements for more than 230 athletic banned substances, which is why the program is used by the NFL, NHL, MLB, PGA, LPGA, the Canadian Centre for Ethics in Sport (CCES) and the New York City Police Department.
     
    “NSF International’s dietary supplement and Certified for Sport certification programs help retailers, consumers and athletes to make more educated decisions knowing that what is on the label matches what is in the container, and that they are not consuming any unintended substances like oxilofrine,” added Mr. Travis. 
     
    Scientists at the NCNPR conducted analyses on the products. “We are pleased to be a part of this research team, which is working to understand the risks and ensure the safety of botanical supplements for consumers,” said Dr. Larry Walker, Director of the NCNPR.
     
    Isolating Offenders
    CRN’s Mr. Mister said the study findings “are particularly troubling to responsible marketers of dietary supplements because they demonstrate once again that rogue companies will ignore the laws designed to protect consumers.”
     
    Oxilofrine is not a legitimate dietary ingredient, and its marketers have not complied with the legal requirements for bringing an NDI to market, he noted. “Oxilofrine, also referred to as methylsynephrine, has not met the legal requirements for demonstrating a reasonable expectation of safety, and thus it raises questions about the potential health risks to consumers who might use these products.”
     
    CRN appreciates the work that Dr. Cohen and the co-authors have done, he added, and hopes it will result in “isolating fringe players that recklessly break the law.”
     
    Urging FDA to use all the resources at its disposal to take action against these companies and to remove the products from the marketplace, Mr. Mister said, “This type of blatant illegal activity is not only disturbing, but also disruptive, to companies in the dietary supplement industry who sell reputable products. When rogue companies use the supplement space to peddle illegal products, like we have in this situation, the legitimate companies have their reputations damaged—and worst of all, consumers are put at risk.”
     
    CRN is part of a coalition that lobbies for FDA to receive additional resources in order to fully enforce the law. “We are committed to doing what we can to help to support both the agency’s and industry’s efforts to protect consumers,” Mr. Mister said. 
    Related Searches
    • fda
    • Stimulants
    • Health
    • sports nutrition
    Related Knowledge Center
    • Sports Nutrition
    • Testing
    • Dietary Supplements
    Suggested For You
    FDA Issues Draft Guidance on NDI Enforcement Discretion FDA Issues Draft Guidance on NDI Enforcement Discretion
    Consumer Conviction: Results of consumer satisfaction study on mental wellness and sleep. Consumer Conviction: Results of consumer satisfaction study on mental wellness and sleep.
    Draft Senate Bill to Reauthorize FDA User Fees Includes Dietary Supplement Listing Provision Draft Senate Bill to Reauthorize FDA User Fees Includes Dietary Supplement Listing Provision
    FDA Warns About Steroids or Steroid-Like Substances in Bodybuilding Products  FDA Warns About Steroids or Steroid-Like Substances in Bodybuilding Products
    Experts Debate Role of Supplements in Improving Public Health in EU Experts Debate Role of Supplements in Improving Public Health in EU
    NSF and SCNM’s School of Nutrition Collaborate on Master of Science Program NSF and SCNM’s School of Nutrition Collaborate on Master of Science Program
    Walgreen’s Brand Vitamins and Supplements First to Carry UL Verified Mark Walgreen’s Brand Vitamins and Supplements First to Carry UL Verified Mark
    Bioiberica Unveils DAOgest and Dermial at Vitafoods 2022 Bioiberica Unveils DAOgest and Dermial at Vitafoods 2022
    Authenticating Ginkgo Biloba Leaf Extract: Lab Guidance Document Reviews Analytical Methods Authenticating Ginkgo Biloba Leaf Extract: Lab Guidance Document Reviews Analytical Methods
    Third-Party Certifications Support Consumer Demand for Quality and Transparency Third-Party Certifications Support Consumer Demand for Quality and Transparency
    Supplement Formulations That Win In Wellness Supplement Formulations That Win In Wellness
    Podcast: Michael McGuffin Discusses Dietary Supplement Regulation and Mandatory Product Listing Bill Podcast: Michael McGuffin Discusses Dietary Supplement Regulation and Mandatory Product Listing Bill
    Marketing Trends in Gaming and Powering Esports Athletes with Nutrition21’s nooLVL® Marketing Trends in Gaming and Powering Esports Athletes with Nutrition21’s nooLVL®
    FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products
    IFF to Discuss Customizable, Sustainable Solutions for Supplements IFF to Discuss Customizable, Sustainable Solutions for Supplements

    Related Content

    • Dietary Supplements | Regulations
      FDA Issues Draft Guidance on NDI Enforcement Discretion

      FDA Issues Draft Guidance on NDI Enforcement Discretion

      Amnesty for late NDI notifications is intended to encourage manufacturers and distributors to correct past failures while collecting safety data, FDA said.
      By Sean Moloughney, Editor 05.20.22

    • Consumer Conviction: Results of consumer satisfaction study on mental wellness and sleep.

      Consumer Conviction: Results of consumer satisfaction study on mental wellness and sleep.

      Register now for our FREE Webinar on Wednesday, June 8, 2022; 10AM EST!
      05.18.22

    • Dietary Supplements | Regulations
      Draft Senate Bill to Reauthorize FDA User Fees Includes Dietary Supplement Listing Provision

      Draft Senate Bill to Reauthorize FDA User Fees Includes Dietary Supplement Listing Provision

      HELP Committee released discussion draft that includes language similar to Senate Bill 4090 introduced last month by Senators Durbin and Braun.
      By Sean Moloughney, Editor 05.18.22


    • Breaking News | Dietary Supplements | Industry & Market News | Quality & Safety | Sports Nutrition
      FDA Warns About Steroids or Steroid-Like Substances in Bodybuilding Products

      FDA Warns About Steroids or Steroid-Like Substances in Bodybuilding Products

      According to the agency, these products are promoted as hormone products or alternatives to anabolic steroids.
      05.18.22

    • Dietary Supplements | Healthy Aging | Regulations | World Markets
      Experts Debate Role of Supplements in Improving Public Health in EU

      Experts Debate Role of Supplements in Improving Public Health in EU

      At a panel discussion supported by Food Supplements Europe, stakeholders discussed regulation, bridging nutrient gaps, nutrition literacy, and more.
      By Mike Montemarano, Associate Editor 05.16.22

      Trending
      • Leaven Essential To Launch Branded Botanical Extracts To Global Markets | Nutraceuticals World
      • Oregon Files Lawsuit Against GNC | Nutraceuticals World
      • Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk In Older Adults | Nutraceuticals World
      • Coca-Cola To Phase Out Honest Tea Brand By Year’s End, Citing Supply Chain Challenges | Nutraceuticals World
      Breaking News
      • Thorne Relaunches Gut Health Test with Microbiome Wipe
      • Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports
      • GC Rieber Foundations Expand Philanthropic Efforts
      • Danone Celebrates 10th anniversary of Grant Program for Probiotics Research
      • Stratum Nutrition’s Patent Portfolio Grows to Europe and Canada
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Aging in Place: Lifestyle Supplements Science-Based Solutions
      • Getting an Edge in Esports: Meeting Health & Nutrition Needs
      • Nutraceuticals for Men: Muscle Health and Performance Nutrition

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports
      GC Rieber Foundations Expand Philanthropic Efforts
      Coatings World

      Latest Breaking News From Coatings World

      PPG Sets Goals to Reduce Greenhouse Gas Emissions, Unveils 2021 ESG Report
      Birla Carbon to Present Sustainable Carbon-based Solutions at PaintIndia 2022
      BTC Europe, NXTLEVVEL Biochem to Distribute Biobased & Biodegradable Solvents in Europe
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Anumana's ECG Pulmonary Hypertension AI Algorithm Gains Breakthrough Status
      inHEART's 3D Cardiac Modeling Tool Earns FDA Nod
      FDA OKs RapidAI's Pulmonary Embolism Triage, Notification Tool
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Corealis CDMO Completes Deal with ArchiMed
      Piramal Pharma Solutions Upgrades Oral Solid Dose Capabilities
      Steriline Robotic Applications to Improve Quality in Drug Primary Packaging
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      L'Oreal CEO Nicolas Hieronimus On Sustainability Initiatives
      Glossier Announces New CEO
      Men’s Skincare Market to Hit $13 Billion by End of 2022
      Happi

      Latest Breaking News From Happi

      Zocdoc’s Appointment Analysis Shows Consumers Are Seeking Skin Health Care in Person Again
      Four Seasons Resort Maui To Offer Project Reef Sunscreen Beginning on World Oceans Day
      IFSCC Extends 2022 Early Bird Registration
      Ink World

      Latest Breaking News From Ink World

      HP Indigo Reaches 2,000th Active Install
      Siegwerk Introduces New NC-Based Flexible Packaging Ink
      Sun Chemical Expands SunColorBox with SunConnect
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      AWA to host 22nd Global Release Liner Industry Conference & Exhibition
      Domino assists Grace Label with supply chain disruptions
      Rotocon wins AI Business Excellence Award
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Thinx Names Meghan Davis as CEO
      Kimberly-Clark Reportedly Examining Sale of Latin American Tissue
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Extremity Medical Rolls Out OMNI Stable Ankle Fracture System
      James W. Stone Named AANA President
      Tom Hedman Named Senior Principal Scientist at Spinal Simplicity
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Canatu Receives IATF 16949:2016 Certification
      Applied Materials Announces 2Q 2022 Results
      ams OSRAM Supervisory Board to Elect Dr. Margarete Haase as Chairwoman

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login